MPM Oncology Impact Management GP LLC is 10% Owner at Harpoon Therapeutics, Inc. (HARP). They have made 6 open-market trades across 2 companies since 2020, most recently 2021-08-11.
CIK 0001721035
1 open-market purchase totalling $6.1M since 2020, against 5 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 100% | 100% |
| Avg Move | -5.7% | -20.4% | -52.1% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CGEM | SELL · 10b5-1 | 2021-08-11 | 2021-08-12 | $29.05 | $73K | +5.7% | +2.9% | -19.9% |
| HARP | SELL | 2021-05-26 | 2021-05-27 | $20.22 | $694K | -28.3% | -34.3% | -56.2% |
| HARP | SELL | 2021-05-18 | 2021-05-20 | $20.49 | $2.0M | +1.7% | -26.8% | -54.4% |
| HARP | SELL | 2021-05-13 | 2021-05-17 | $20.06 | $520K | +1.7% | -23.8% | -55.8% |
| HARP | SELL | 2021-04-30 | 2021-05-04 | $22.48 | $14.7M | -16.8% | -9.3% | -55.5% |
| HARP | SELL | 2021-04-21 | 2021-04-22 | $18.96 | $330K | +13.2% | -7.8% | -38.6% |
| ITOS | BUY | 2020-07-28 | 2020-07-30 | $19.00 | $6.1M | +58.0% | +54.3% | +21.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.